F. Piu

Publications12
h-index4
Citations877
Highly Influential Citations29
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Karin
  • 805 Publications, 219,845 Citations
  • E. Wagner
  • 371 Publications, 46,411 Citations
  • P. Angel
  • 208 Publications, 23,273 Citations
  • B. Vogelstein
  • 858 Publications, 306,876 Citations
  • Publications
  • Influence
Control of cell cycle progression by c-Jun is p53 dependent.
The c-jun proto-oncogene encodes a component of the mitogen-inducible immediate-early transcription factor AP-1 and has been implicated as a positive regulator of cell proliferation and G1-to-S-phase… Expand
  • 540
  • 16
The Mammalian UV Response c-Jun Induction Is Required for Exit from p53-Imposed Growth Arrest
The mammalian UV response results in rapid and dramatic induction of c-jun. Induction of a protooncogene, normally involved in mitogenic responses, by a genotoxic agent that causes growth arrest… Expand
  • 295
  • 11
Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator
Because of the limitations and liabilities of current testosterone therapies, non-steroidal tissue-selective androgen receptor modulators may provide a clinically meaningful advance in therapy. Using… Expand
  • 24
  • 2
Selective androgen receptor modulators antagonize apolipoprotein E4-induced cognitive impairments
  • 13
392 A SELECTIVE ESTROGEN RECEPTOR BETA AGONIST MODULATES NEUROPATHIC AND INFLAMMATORY PAIN STATES
Background and aims. The effects of estrogens on pain perception remain quite controversial. Depending on the animal models, both beneficial and detrimental effects of non-selective estrogens have… Expand
  • 1
Transforming growth factor beta 1-mediated growth inhibition in chick embryo fibroblasts: reversion by virally-expressed nuclear oncogenes.
Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of primary cultures of chick embryo fibroblasts by affecting G1 and strongly increasing the generation time. This inhibition is reversed… Expand
  • 4
Funcational assay platform to identify novel inhibitors of receptor tyrosine kinases
3144 Background: ACADIA has developed a functional assay to detect Receptor Tyrosine Kinase (RTK) activity, using its unique proprietary platform technology Receptor and Selection Amplification… Expand
Identification of histamine H3 receptor antagonists
In vitro and in vivo profile of a novel tissue selective, orally bioavailable non-steroidal androgen receptor modulator (ACP-105)
Clinical experience with testosterone suggests a wide range of indications for selective androgen receptors modulators (SARMs), including hypogonadism, osteoporosis, CNS indications and muscle wast...
Identification of novel antagonists of CB1 cannabinoid receptors